Glycogen storage disease type III can follow a progressive hepatic course. In a distinct subset of patients, this progression reaches advanced liver disease — cirrhosis accompanied by significantly impaired synthetic function — a clinical threshold that shifts the management approach.
Glycogen storage disease type III complicated by advanced liver disease: cirrhosis with impaired synthetic function. While histologic evidence of cirrhosis may develop in GSD III, it is the loss of adequate hepatic synthetic capacity that defines this higher-acuity scenario and drives the management decision described in the full protocol.
When hepatic synthetic function is significantly compromised, management in this setting involves consideration of a surgical organ-replacement procedure. The full protocol — including the complete structured approach, eligibility criteria, and evaluation pathway — is available below.
DOI: 10.1097/GIM.0b013e3181e655b6
It has been suggested that individuals with GSD III and advanced liver disease should be considered for liver transplant.
Although individuals with GSD III may develop histologic evidence of cirrhosis, so long as their synthetic function remains normal or well preserved, liver transplantation (LT) is not necessary.
View source ↗